AML
Latest News
`Wonder Woman’ launches myelofibrosis research foundation
Honoring her late husband’s battle with a bone marrow disorder, TV actor Lynda Carter establishes a research foundation.
From the Journals
Pivotal trials in blood cancers don’t mirror patient populations
“The results from this study should lead to questions about the generalizability of drug safety and efficacy in populations we serve as medical...
Bloodlines
Bias and other barriers to HSCT access
A view from the world of cellular therapy and hematopoietic stem cell transplantation.
News
First drug therapy approved for childhood GVHD
FDA greenlights ibrutinib for child blood cancer patients with chronic graft-versus-host disease.
From the Journals
AML’s seasonal peak suggests viral or environmental etiology
“The environmental triggers involved could be radiation, pollution, allergens, or infectious agents like viruses.”
Conference Coverage
Fourth patient cleared of HIV after stem cell transplant for blood cancer
“Although a transplant is not an option for most people with HIV, these cases are still interesting, still inspiring, and help illuminate the...
Conference Coverage
‘Superior’ CLL regimen cuts chemo in half
Where chemo is still used to treat CLL, this three-cycle regimen combined with ibrutinib and obinutuzumab shows progression-free and overall...
Guidelines
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.
Conference Coverage
‘Extremely exciting’ study results guide MM treatment options
New trial data help inform the tailoring of effective treatment approaches for patients with newly diagnosed multiple myeloma (MM).
Feature
Third-generation Black woman physician makes cancer research history
African American surgeon helped found ASCO and collaborated with her father to achieve lasting breakthroughs in chemotherapy.
From the Journals
Young leukemia survivors still dying early, study shows
‘Cure is not enough’ for adolescent and young adult survivors of leukemia, with new data indicating that their life spans are still cut short.